| * TWEAK induces liver progenitor cell proliferation |
| * The cytoskeletal protein ezrin regulates EC proliferation and angiogenesis via TNF--induced transcriptional repression of cyclin A |
| * 2005 Association of American Physicians Kober Medal. Acceptance of the 2005 Kober Medal |
| * Of rice and men: Bill Kelley's next generation |
| * 2005 Association of American Physicians Presidential Address. Academia-industry collaboration: A dynamic partnership on behalf of patients |
| * Cathepsin L is essential for onset of autoimmune diabetes in NOD mice |
| * Arsenic trioxide inhibits nuclear receptor function via SEK1/JNK-mediated RXR phosphorylation |
| * Human 1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by 1?1 integrin |
| * TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs |
| * Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions |
| * Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney |
| * Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative response |
| * Apoptosis modulates protective immunity to the pathogenic fungus Histoplasma capsulatum |
| * Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo |
| * Epithelial myosin light chain kinase–dependent barrier dysfunction mediates T cell activation–induced diarrhea in vivo |
| * The potential role of amyloid ? in the pathogenesis of age-related macular degeneration |
| * A molecular chaperone for mitochondrial complex I assembly is mutated in a progressive encephalopathy |
| * Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment |
| * Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor |
| * Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation |
| * MMP13 mutation causes spondyloepimetaphyseal dysplasia, Missouri type (SEMDMO) |
| * An interstitial deletion-insertion involving chromosomes 2p25.3 and Xq27.1, near SOX3, causes X-linked recessive hypoparathyroidism |
| * Reversal of experimental pulmonary hypertension by PDGF inhibition |
| * A role for docosahexaenoic acid–derived neuroprotectin D1 in neural cell survival and Alzheimer disease |
| * Deficits in amygdaloid cAMP-responsive element–binding protein signaling play a role in genetic predisposition to anxiety and alcoholism |
| * Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice |
| * FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner |
| * IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis |
| * Atrial natriuretic peptide promotes cardiomyocyte survival by cGMP-dependent nuclear accumulation of zyxin and Akt |
| * Shifting gears: liver SR-BI drives reverse cholesterol transport in macrophages |
| * The anxious amygdala: CREB signaling and predisposition to anxiety and alcoholism |
| * Autophagy in cell death: an innocent convict? |
| * Reawakening the cellular death program in neoplasia through the therapeutic blockade of IAP function |
| * Give me A5 for lipoprotein hydrolysis! |
| * PDGF signaling in pulmonary arterial hypertension |
| * Mining yeast in silico unearths a golden nugget for mitochondrial biology |
| * Caspases: pharmacological manipulation of cell death |
| * Endoplasmic reticulum stress: cell life and death decisions |
| * Pharmacological manipulation of Bcl-2 family members to control cell death |
| * Mitochondria: pharmacological manipulation of cell death |
| * Death versus survival: functional interaction between the apoptotic and stress-inducible heat shock protein pathways |
| * IKK/NF-B signaling: balancing life and death – a new approach to cancer therapy |
| * The survival kinases Akt and Pim as potential pharmacological targets |
| * Pharmacological manipulation of cell death: clinical applications in sight? |
| * Kidney stone disease |
| * Untying the Gordian knot: policies, practices, and ethical issues related to banking of umbilical cord blood |
| * Postcards from the brain museum: The improbable search for meaning in the matter of famous minds |
| * Testosterone dreams: Rejuvenation, aphrodisia, doping |
| * In the quest to stymie time, will laboratory data stand up in man? |
| * Nucleic acid sequence data turns 100,000,000,000 and looks to the future |
| * Q & A with the man who can stop cervical cancer in its tracks |
| * In this issue |
| * Don’t be stupid about intelligent design |
| * Feeding cats might be dangerous: penetrating orbital and brain injury without neurological deficits |
| * Cognitive neuropsychology of Alzheimer’s disease |
| * Neurological rehabilitation of stroke |
| * Excessive daytime sleepiness in migraine patients |
| * Mild impairments in cognition in patients with type 2 diabetes mellitus: the use of the concepts MCI and CIND |
| * Leech therapy in the treatment of median nerve compression due to forearm haematoma |
| * Use of mechanical extraction devices in basilar artery occlusion |
| * Difficulty in diagnosing chronic meningitis caused by capsule-deficient Cryptococcus neoformans |
| * Suicide among Danes with multiple sclerosis |
| * Protein S deficiency in HIV associated ischaemic stroke: an epiphenomenon of HIV infection |
| * Visual inspection versus spectrophotometry in detecting bilirubin in cerebrospinal fluid |
| * Longitudinal change in 99mTcHMPAO cerebral perfusion SPECT in Parkinson’s disease over one year |
| * Reliability and validity of the Geriatric Depression Scale in depression in Parkinson’s disease |
| * APOE related alterations in cerebral activation even at college age |
| * Simulconsult: www.simulconsult.com |
| * T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barré syndrome and chronic inflammatory demyelinatin |
| * Long term experience of gamma knife radiosurgery for benign skull base meningiomas |
| * Should coeliac disease be considered in the work up of patients with chronic peripheral neuropathy? |
| * Prevalence and characteristics of patients in a vegetative state in Dutch nursing homes |
| * Clinical spectrum of cryoglobulinaemic neuropathy |
| * Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I |
| * Fatigue and daytime sleepiness rating scales in myotonic dystrophy: a study of reliability |
| * Short latency disconjugate vestibulo-ocular responses to transient stimuli in the audio frequency range |
| * Do children with developmental dyslexia have an implicit learning deficit? |
| * Autobiographical amnesia and accelerated forgetting in transient epileptic amnesia |
| * Reliability and validity of the Geriatric Depression Scale in depression in Parkinson’s disease |
| * Suppressed circadian heart rate dynamics in temporal lobe epilepsy |
| * Epstein-Barr virus and disease activity in multiple sclerosis |
| * Recanalisation of middle cerebral artery occlusion after intra-arterial thrombolysis: different recanalisation grading systems and clinical |
| * A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients |
| * Twenty four hour pulse pressure predicts long term recurrence in acute stroke patients |
| * Mirror movements in parkinsonism: evaluation of a new clinical sign |
| * Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer’s disease? |
| * Anosmia is very common in the Lewy body variant of Alzheimer’s disease |
| * Neuropsychiatric profiles in patients with Alzheimer’s disease and vascular dementia |
| * Management of asymptomatic carotid stenosis in patients undergoing general and vascular surgical procedures |
| * HIV infection and stroke: if not protein S deficiency then what explains the relationship? |
| * Mirror movements in neurology |
| * Arteriovenous malformations of the brain: ready to randomise? |